Manuel L. Fernández Guerrero-rekin lankidetzan egindako argitalpenak (7)

2021

  1. HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers

    AIDS, Vol. 35, Núm. 3, pp. 393-398

2020

  1. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

    Journal of Molecular Medicine, Vol. 98, Núm. 8, pp. 1093-1105

2018

  1. CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART

    Scientific Reports, Vol. 7, Núm. 1

2008

  1. Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced disease

    HIV Clinical Trials, Vol. 9, Núm. 2, pp. 83-90

2005

  1. A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load

    HIV Medicine, Vol. 6, Núm. 5, pp. 353-359

2004

  1. Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load

    Clinical Infectious Diseases, Vol. 39, Núm. 7, pp. 1024-1029